Table I.

Donor and graft characteristics.

Demographics	Numbers (range)
Sample size	22
Donor age	62 (45–76)
Weight (kg)	101.4 (57.7–129.5)
Males	16
Females	6
Co-morbidity and medications	%
Donors with diabetes	52.6
Donors with prior myocardial infarction	75.1
Donors on angiotensin-converting enzyme inhibitor	56.2
Donors on beta-blockers	94
Donors on statins	90.4
Severity of coronary artery disease	Mean (SD)
Prior percutaneous coronary intervention (PCI)	2.9 (3.1)
Prior coronary artery bypass graft (CABG)	1.3 (0.6)
SPECT left ventricular ejection fraction (LVEF)	60.1 (14)
Cell counts and viability	Median (range)
Peripheral blood CD34+ cell count/μL	22.6 (10.7–71.2)
Pre-selection total nucleated cell × 108/kg	3.1 (1.22–6.69)
Pre-selection CD34+ cell × 106/kg	0.79 (0.09–3.53)
Pre-selection cell viability (%)	98 (90–99)
Post-selection CD34+ cell (%)	82.5 (47–95.8)
Expression of differentiation markers	Median (range)
Post-selection T cells (CD3+) (%)	1 (0.2–2)
Post-selection B cells (CD20+) (%)	5.5 (2–23)
Post-selection platelets/megakaryocytes (CD41+) (%)	15 (4–81)